The Demise of the Bull's Eye (Screening for Hydroxychloroquine Retinopathy)

Retina

Volumn 36, Issue 10, 2016, Pages 1803-1805

  Marmor, Michael F ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HYDROXYCHLOROQUINE; TAMOXIFEN; ANTIMALARIAL AGENT; ANTIRHEUMATIC AGENT;

DRUG INDUCED DISEASE; DRUG USE; ELECTROOCULOGRAPHY; ELECTRORETINOGRAPHY; HUMAN; KIDNEY DISEASE; PHOTORECEPTOR; PRACTICE GUIDELINE; PROGNOSIS; RETINA; RETINA MACULOPATHY; RETINOPATHY; REVIEW; SCOTOMA; SPECTRAL DOMAIN OPTICAL COHERENCE TOMOGRAPHY; TREATMENT DURATION; VISION; CHEMICALLY INDUCED; DRUG EFFECTS; OPTICAL COHERENCE TOMOGRAPHY; PATHOLOGY; PERIMETRY; RETINAL DISEASES; RISK FACTOR; VISUAL FIELD;

ANTIMALARIALS; ANTIRHEUMATIC AGENTS; ELECTRORETINOGRAPHY; HUMANS; HYDROXYCHLOROQUINE; RETINA; RETINAL DISEASES; RISK FACTORS; TOMOGRAPHY, OPTICAL COHERENCE; VISUAL FIELD TESTS; VISUAL FIELDS;

EID: 84978101028     PISSN: 0275004X     EISSN: 15392864     Source Type: Journal    
DOI: 10.1097/IAE.0000000000001151     Document Type: Review

References (10)

1. Marmor MF, Kellner U, Lai TY, et al. American Academy of Ophthalmology update revised recommendations on screening for chloroquine and hydroxychloroquine retinopathy. Ophthalmology 2011; 118: 415-422.
2. Marmor MF, Kellner U, Lai TY, et al. American Academy of Ophthalmology statement: recommendations on screening for chloroquine and hydroxychloroquine retinopathy (2016 revision). Ophthalmology 2016; 123: 1386-1394.
3. Melles RB, Marmor MF. The risk of toxic retinopathy in patients on long-term hydroxychloroquine therapy. JAMA Ophthalmol 2014; 132: 1453-1460.
4. McChesney EW. Animal toxicity and pharmacokinetics of hydroxychloroquine sulfate. Am J Med 1983; 75: 11-18.
5. Melles RB, Marmor MF. Pericentral retinopathy and racial differences in hydroxychloroquine toxicity. Ophthalmology 2015; 122: 110-116.
6. De Sisternes L, Hu J, Rubin DL, et al. Localization of damage in progressive hydroxychloroquine retinopathy on and off the drug: inner versus outer retina, parafovea versus peripheral fovea. Invest Ophthalmol Vis Sci 2015; 56: 3415-3426.
7. De Sisternes L, Hu J, Rubin DL, et al. Analysis of Inner and Outer Retinal Thickness in Patients Using Hydroxychloroquine Prior to Development of Retinopathy. JAMA Ophthalmol 2016; 134: 511-519.
8. Marmor MF, Melles RB. Disparity between visual fields and optical coherence tomography in hydroxychloroquine retinopathy. Ophthalmology 2014; 121: 1257-1262.
9. Marmor MF. Comparison of screening procedures in hydroxychloroquine toxicity. Arch Ophthalmol 2012; 130: 461-469.
10. Marmor MF, Hu J. Effect of disease stage on progression of hydroxychloroquine retinopathy. JAMA Ophthalmol 2014; 132: 1105-1112.